Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
Mengshu You, Zhuolin Xie, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 118

Showing 51-75 of 118 citing articles:

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer
Kalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0289904-e0289904
Open Access | Times Cited: 3
Cellular and Molecular Mechanisms of Tumor Promotion
Ann M. Bode, Tianshun Zhang
Elsevier eBooks (2024)
Closed Access | Times Cited: 3
Epigenetic reader ZMYND11 noncanonical function restricts HNRNPA1-mediated stress granule formation and oncogenic activity
Lian Cheng, Chunyi Zhang, Pan Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Regulatory-Associated Protein of mTOR-Mediated Signaling: A Nexus Between Tumorigenesis and Disease
Surbhi Chouhan, Anil Kumar, Vikrant Piprode, et al.
Targets (2024) Vol. 2, Iss. 4, pp. 341-371
Open Access | Times Cited: 3
Targeting piRNA‐137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma
Yuning Zhan, Fanglin Tian, Weina Fan, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Gold mineralized “hybrid nanozyme bomb” for NIR-II triggered tumor effective permeation and cocktail therapy
Ji Liu, Dongsheng He, Tianjiao Hao, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 9, pp. 109296-109296
Closed Access | Times Cited: 7
Liver Stiffness Values to Predict Occurrence and Recurrence of Hepatocellular Carcinoma
Cristina Stasi, S. Brillanti
Life (2024) Vol. 14, Iss. 3, pp. 342-342
Open Access | Times Cited: 2
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
Domiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2110-2110
Open Access | Times Cited: 2
Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation
Jing Yu, Yongjun Du, Chang Liu, et al.
Life Sciences (2024) Vol. 350, pp. 122763-122763
Closed Access | Times Cited: 2
Molecular Mechanism of Cell Signaling Pathways of Cancer Cells in Forward and Reverse Mutation: A Perspective Review
Naeema Salatia Hoque, Md. Sakhawat Hossain, Md. Ashikur Rahaman, et al.
Journal of Cancer and Tumor International (2024) Vol. 14, Iss. 3, pp. 46-57
Open Access | Times Cited: 2
Identification of serum metabolites associated with polybrominated diphenyl ethers (PBDEs) exposure in papillary thyroid carcinoma: a case–control study
Jiayi Song, Yuan Liu, Jinling Peng, et al.
Environmental Geochemistry and Health (2024) Vol. 46, Iss. 10
Open Access | Times Cited: 2
Oncofetal TRIM71 drives liver cancer carcinogenesis through remodeling CEBPA-mediated serine/glycine metabolism
Ying Su, Ziteng Li, Qin Li, et al.
Theranostics (2024) Vol. 14, Iss. 13, pp. 4948-4966
Open Access | Times Cited: 2
Identification of circulating metabolites linked to the risk of breast cancer: a mendelian randomization study
Xiaosheng Zhu, Huai Huang, Mengjie Zou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Programmable Nanomodulators for Precision Therapy, Engineering Tumor Metabolism to Enhance Therapeutic Efficacy
Siwei Liu, Zhijun Liu, Huajiang Lei, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 2
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Hua Yang, Yang Xun, Chao Ke, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 6
Nano Strategies for Artemisinin Derivatives to Enhance Reverse Efficiency of Multidrug Resistance in Breast Cancer
Xueyan Zhang, Na Li, Guoqin Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 43, pp. 3458-3466
Closed Access | Times Cited: 6
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
Qihai Sui, Huiqiang Yang, Zhengyang Hu, et al.
Pharmaceutical Research (2024)
Closed Access | Times Cited: 1
Decoding the role of SPRR1A and SPRR1B gene in cancer: A comprehensive review
Raushan Kumar Chaudhary, Prakash Patil, Vijith Shetty, et al.
Gene Reports (2024) Vol. 36, pp. 101926-101926
Closed Access | Times Cited: 1
Cracking the Codes behind Cancer Cells’ Immune Evasion
Nikita Mundhara, Pritam Sadhukhan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8899-8899
Open Access | Times Cited: 1
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer
Yang Zhang, Qianming Kang, Luying He, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy
Xinyan Li, Jiayi Xu, Liangwen Yan, et al.
Metabolites (2024) Vol. 14, Iss. 11, pp. 604-604
Open Access | Times Cited: 1
PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination
Shuai Zhang, Shuling Zhang, Baijuan Xia, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 1
Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug
Wenqiang Li, Mei Li, Qian Huang, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 3
The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells
Kausik Bishayee, Seung-Hee Lee, Yong Soo Park
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13928-13928
Open Access | Times Cited: 3

Scroll to top